250 related articles for article (PubMed ID: 36311728)
1. CXCR6 expressing T cells: Functions and role in the control of tumors.
Mabrouk N; Tran T; Sam I; Pourmir I; Gruel N; Granier C; Pineau J; Gey A; Kobold S; Fabre E; Tartour E
Front Immunol; 2022; 13():1022136. PubMed ID: 36311728
[TBL] [Abstract][Full Text] [Related]
2. CXCR6 deficiency impairs cancer vaccine efficacy and CD8
Karaki S; Blanc C; Tran T; Galy-Fauroux I; Mougel A; Dransart E; Anson M; Tanchot C; Paolini L; Gruel N; Gibault L; Lepimpec-Barhes F; Fabre E; Benhamouda N; Badoual C; Damotte D; Donnadieu E; Kobold S; Mami-Chouaib F; Golub R; Johannes L; Tartour E
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33692218
[TBL] [Abstract][Full Text] [Related]
3. Single-cell RNA transcriptome analysis of CNS immune cells reveals CXCL16/CXCR6 as maintenance factors for tissue-resident T cells that drive synapse elimination.
Rosen SF; Soung AL; Yang W; Ai S; Kanmogne M; Davé VA; Artyomov M; Magee JA; Klein RS
Genome Med; 2022 Sep; 14(1):108. PubMed ID: 36153630
[TBL] [Abstract][Full Text] [Related]
4. CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways.
Wein AN; McMaster SR; Takamura S; Dunbar PR; Cartwright EK; Hayward SL; McManus DT; Shimaoka T; Ueha S; Tsukui T; Masumoto T; Kurachi M; Matsushima K; Kohlmeier JE
J Exp Med; 2019 Dec; 216(12):2748-2762. PubMed ID: 31558615
[TBL] [Abstract][Full Text] [Related]
5. CXCR6 is required for antitumor efficacy of intratumoral CD8
Wang B; Wang Y; Sun X; Deng G; Huang W; Wu X; Gu Y; Tian Z; Fan Z; Xu Q; Chen H; Sun Y
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34462326
[TBL] [Abstract][Full Text] [Related]
6. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor.
Yoon MS; Pham CT; Phan MT; Shin DJ; Jang YY; Park MH; Kim SK; Kim S; Cho D
Cytotherapy; 2016 Dec; 18(12):1532-1542. PubMed ID: 27720639
[TBL] [Abstract][Full Text] [Related]
7. Role of the CXCR6/CXCL16 axis in autoimmune diseases.
Bao N; Fu B; Zhong X; Jia S; Ren Z; Wang H; Wang W; Shi H; Li J; Ge F; Chang Q; Gong Y; Liu W; Qiu F; Xu S; Li T
Int Immunopharmacol; 2023 Aug; 121():110530. PubMed ID: 37348231
[TBL] [Abstract][Full Text] [Related]
8. CXCR6 by increasing retention of memory CD8
Muthuswamy R; McGray AR; Battaglia S; He W; Miliotto A; Eppolito C; Matsuzaki J; Takemasa T; Koya R; Chodon T; Lichty BD; Shrikant P; Odunsi K
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34607898
[TBL] [Abstract][Full Text] [Related]
9. CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.
Lee LN; Ronan EO; de Lara C; Franken KL; Ottenhoff TH; Tchilian EZ; Beverley PC
Infect Immun; 2011 Aug; 79(8):3328-37. PubMed ID: 21628524
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
[TBL] [Abstract][Full Text] [Related]
11. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
12. Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells.
Tabata S; Kadowaki N; Kitawaki T; Shimaoka T; Yonehara S; Yoshie O; Uchiyama T
J Leukoc Biol; 2005 May; 77(5):777-86. PubMed ID: 15703197
[TBL] [Abstract][Full Text] [Related]
13. CXCR6-Deficiency Improves the Control of Pulmonary
Ashhurst AS; Flórido M; Lin LCW; Quan D; Armitage E; Stifter SA; Stambas J; Britton WJ
Front Immunol; 2019; 10():339. PubMed ID: 30899256
[TBL] [Abstract][Full Text] [Related]
14. Functional role of endothelial CXCL16/CXCR6-platelet-leucocyte axis in angiotensin II-associated metabolic disorders.
Collado A; Marques P; Escudero P; Rius C; Domingo E; Martinez-Hervás S; Real JT; Ascaso JF; Piqueras L; Sanz MJ
Cardiovasc Res; 2018 Nov; 114(13):1764-1775. PubMed ID: 29800106
[TBL] [Abstract][Full Text] [Related]
15. Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells.
Germanov E; Veinotte L; Cullen R; Chamberlain E; Butcher EC; Johnston B
J Immunol; 2008 Jul; 181(1):81-91. PubMed ID: 18566372
[TBL] [Abstract][Full Text] [Related]
16. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
Darash-Yahana M; Gillespie JW; Hewitt SM; Chen YY; Maeda S; Stein I; Singh SP; Bedolla RB; Peled A; Troyer DA; Pikarsky E; Karin M; Farber JM
PLoS One; 2009 Aug; 4(8):e6695. PubMed ID: 19690611
[TBL] [Abstract][Full Text] [Related]
17. The role of the CXCR6/CXCL16 axis in the pathogenesis of fibrotic disease.
Wang FT; Wu TQ; Lin Y; Jiao YR; Li JY; Ruan Y; Yin L; Chen CQ
Int Immunopharmacol; 2024 May; 132():112015. PubMed ID: 38608478
[TBL] [Abstract][Full Text] [Related]
18. Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model.
Kee JY; Ito A; Hojo S; Hashimoto I; Igarashi Y; Tsukada K; Irimura T; Shibahara N; Nakayama T; Yoshie O; Sakurai H; Saiki I; Koizumi K
Oncol Rep; 2013 Mar; 29(3):975-82. PubMed ID: 23242131
[TBL] [Abstract][Full Text] [Related]
19. CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease.
Zhu H; Zhang Q; Chen G
Int Immunopharmacol; 2019 Jul; 72():224-234. PubMed ID: 31002999
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance.
Jiang X; Shimaoka T; Kojo S; Harada M; Watarai H; Wakao H; Ohkohchi N; Yonehara S; Taniguchi M; Seino K
J Immunol; 2005 Aug; 175(4):2051-5. PubMed ID: 16081769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
